Related Experiment Video
Updated: Apr 19, 2026
Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
Roles of mitophagy and immune infiltration in Parkinson's disease: new perspectives from bioinformatics analysis and
Xuesong Li1, Yujia Zhang2, Qianwen Yang1
1Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Background:
Mitophagy plays a critical role in the pathology of Parkinson's disease (PD) via mitochondrial quality control, making it a promising therapeutic target. However, the precise mechanistic role of mitophagy in PD pathogenesis and progression remains unclear.
Methods:
We conducted a bioinformatic analysis to identify hub mitophagy-related differentially expressed genes (hub-MPDEGs). The mRNA expression levels of these identified genes were validated using two single-cell RNA sequencing datasets (GSE178265 and PRJNA1145007) and further confirmed in an α-synuclein A53T transgenic mouse model.
Results:
Five hub-MPDEGs were identified: CANX, GABARAPL1, HSPD1, PPARGC1A, and TOMM20. Transcriptomic analysis revealed elevated abundance of these genes in α-synuclein A53T mice compared to controls. Single-cell resolution analysis demonstrated significant differential expression of these genes in astrocytes, dopamine neurons, glutamatergic neurons, endothelial cells, and oligodendrocyte precursor cells within the substantia nigra of PD samples compared to controls. Furthermore, significant differences in mRNA levels were observed in peripheral immune cells, specifically CD4+ T cells, CD8+ T cells, monocytes, and NK cells, between control and PD samples.
Conclusions:
This study identifies and validates five key mitophagy-related genes that are differentially regulated in the central nervous system and peripheral immune cells in the context of Parkinson's disease. These findings highlight the systemic nature of mitophagy dysregulation in PD.
Insights
Five key mitophagy genes are dysregulated in Parkinson's disease (PD) brain and immune cells, suggesting a systemic issue in mitochondrial quality control that could be targeted for PD treatment.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Mitophagy, a cellular process for removing damaged mitochondria, is crucial for maintaining mitochondrial quality control.
- Dysfunctional mitophagy is implicated in Parkinson's disease (PD) pathogenesis, but its precise role is not fully understood.
- Identifying specific mitophagy-related genes involved in PD is essential for developing targeted therapies.
Purpose of the Study:
- To identify and validate key mitophagy-related genes differentially expressed in Parkinson's disease.
- To investigate the expression patterns of these genes in both the central nervous system and peripheral immune cells.
- To elucidate the systemic role of mitophagy dysregulation in PD.
Main Methods:
- Bioinformatic analysis was employed to identify hub mitophagy-related differentially expressed genes (hub-MPDEGs).
- mRNA expression levels were validated using single-cell RNA sequencing datasets (GSE178265 and PRJNA1145007).
- Findings were further confirmed in an alpha-synuclein A53T transgenic mouse model of PD.
Main Results:
- Five hub-MPDEGs were identified: CANX, GABARAPL1, HSPD1, PPARGC1A, and TOMM20.
- These genes showed elevated expression in the alpha-synuclein A53T mouse model.
- Differential expression was observed in various brain cells (astrocytes, dopamine neurons, etc.) and peripheral immune cells (T cells, monocytes, NK cells) in PD samples.
Conclusions:
- This study successfully identified and validated five critical mitophagy-related genes in PD.
- These genes are differentially regulated in both the brain and peripheral immune system of PD patients.
- The findings underscore the systemic nature of mitophagy dysregulation in Parkinson's disease, highlighting potential therapeutic avenues.
More Related Videos
15:09The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
06:57Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells
Published on: May 12, 2023
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
01:15Parkinson's Disease: Overview
01:19Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
01:24Parkinson Disease l: Introduction
01:27Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...